Timoptic-XE 0.5 % Ophthalmic Gel Forming Solution
RxNorm 861422
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 861422 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Timoptic-XE 0.5 % Ophthalmic Gel Forming Solution.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
Timolol 0.005 mg/MG Ophthalmic Gel [Timoptic]
(Atom ID: 12365591)
SYPrescribable
Synonym (SY):
Timoptic 0.005 mg/MG Ophthalmic Gel
(Atom ID: 2990439)
SYPrescribable
Synonym (SY):
Timoptic-XE 0.005 mg/MG Ophthalmic Gel
(Atom ID: 2990407)
SYPrescribable
Synonym (SY):
Timoptic-XE 0.5 % Gel Forming Solution
(Atom ID: 2990408)
PSNPrescribable
Prescribable Name (PSN):
Timoptic-XE 0.5 % Ophthalmic Gel Forming Solution
(Atom ID: 6390930)
Patient Education
Timolol Ophthalmic
Ophthalmic timolol is used to treat glaucoma, a condition in which increased pressure in the eye can lead to gradual loss of vision. Timolol is in a class of medications called beta-blockers. It works by decreasing the pressure in the eye.
[Learn More]
* Please review the disclaimer below.